| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/16/2000 | CN1263598A Antibodies and SCFV immunotoxins specific to imported fire ants, and their application |
| 08/16/2000 | CN1263560A Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in sample of normal cells |
| 08/16/2000 | CN1263556A Anti-GPIIB/IIIA recombinant antibodies |
| 08/16/2000 | CN1263535A LH-RH peptide analogues, their uses and pharmaceutical compositions containing them |
| 08/16/2000 | CN1263534A A preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium |
| 08/16/2000 | CN1263473A Composition and method for enhancing transport across biological membranes |
| 08/16/2000 | CN1263469A Pharmaceutical compositions of peptides having low solubility in physiological medium |
| 08/16/2000 | CN1263154A Human tumor suppressor gene |
| 08/16/2000 | CN1055500C DNA sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom |
| 08/16/2000 | CN1055480C Substitution analogues of magainin peptides |
| 08/16/2000 | CN1055479C Cardiovascular active polypeptide and its synthesis and medical use |
| 08/16/2000 | CN1055394C Medicinal composition for treating postoperative syndrome of gallbladder |
| 08/15/2000 | US6103910 D-proline derivatives |
| 08/15/2000 | US6103890 Enzymatic nucleic acids that cleave C-fos |
| 08/15/2000 | US6103887 For diagnosis of cell proliferation and tumorigenesis especially related to hepatocellular carcinoma; antisense agents; anticarcinogenic agents; antitumor agents |
| 08/15/2000 | US6103881 GnRH analogs for destroying gonadotrophs |
| 08/15/2000 | US6103880 Amino acid sequence of mitogenic peptide; angiogenic agents especially for brain structures; wound healing agents for skin; for bone regeneration especially osteoporosis |
| 08/15/2000 | US6103879 Bivalent molecules that form an activating complex with an erythropoietin receptor |
| 08/15/2000 | US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer |
| 08/15/2000 | US6103875 Antifungal compounds from pseudomonas viridiflava |
| 08/15/2000 | US6103874 Human KDEL receptor |
| 08/15/2000 | US6103873 Isolated renal cancer specific antigen |
| 08/15/2000 | US6103871 Polypeptide of specific amino acid sequence or encoded by cdna in attc deposit number 75882; hydrolyzes oxidized guanine nucleotides to ensure correct dna synthesis; for anticarcinogenic/antitumor agents; diagnostic assays |
| 08/15/2000 | US6103870 CS-1 peptidomimetic, compositions and methods of using the same |
| 08/15/2000 | US6103869 Isolated polypeptide with a mutation at amino acid 464, 465, and/or 467 resulting in dominant negative inhibition of transforming growth factor-beta signaling; therapy and diagnosis of related diseases |
| 08/15/2000 | US6103760 Aminotetralin derivative for the therapy of cardiovascular diseases |
| 08/15/2000 | US6103739 Metalloproteinase inhibitors |
| 08/15/2000 | US6103722 Ischemic preconditioning |
| 08/15/2000 | US6103711 Inhibitors of interleukin-1β converting enzyme |
| 08/15/2000 | US6103705 Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound |
| 08/15/2000 | US6103699 Immunosuppressive agent |
| 08/15/2000 | US6103698 Useful in treating cancer in a mammal; in combination with paclitaxel and taxotere |
| 08/15/2000 | US6103697 Novel homodimers that include cysteine-containing peptides having 4-15 amino acid residues |
| 08/15/2000 | US6103695 Introducing a therapeutically effective dose of a pharmaceutical composition comprising tgfbeta into the pleural cavity |
| 08/15/2000 | US6103694 Method of decreasing radiation of radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| 08/15/2000 | US6103693 Method for isolation of highly pure von willebrand factor |
| 08/15/2000 | US6103692 Administering to said mammal, or contacting said cells with, a compound which inhibits lipid-dependent direct binding of a non-effector loop domain of ras with a raf zinc finger domain |
| 08/15/2000 | US6103691 Administering an agent containing one or more active ingredients selected from the group consisting of angiogenine, alpha1-microglobulin, complement factor d, fragments or peptides |
| 08/15/2000 | US6103690 Prevention or inhibition of pathogenic syndromes caused by nitric oxide overproduction using iron-containing hemoprotein |
| 08/15/2000 | US6103689 Inhibiting p75 nerve growth factor receptor-mediated apoptosis in the melanocyte by contacting melanocytes with an isolated ligand, wherein the ligand comprises a neurotrophin selected from nerve growth factor, neurotrophins-3 and 4/5 |
| 08/15/2000 | US6103527 Nucleotide sequence from gene expressed in proliferating endothelial cells; for controlled gene expression especially for transgenic tissues and gene therapy |
| 08/15/2000 | US6103525 For immunoaffinity purification of enzyme from human blood fractions |
| 08/15/2000 | US6103513 Novel proteolytic enzyme; for the treatment of immune, proliferative and degratory defects |
| 08/15/2000 | US6103507 Protein used to raise an immunological response against a bacteria; bactericides |
| 08/15/2000 | US6103501 Recombinant protein which can be utilized as agonist or antagonist to its native cellular counterparts |
| 08/15/2000 | US6103500 Production of tissue factor pathway inhibitor |
| 08/15/2000 | US6103499 Inhibitors of human plasmin derived from the Kunitz domains |
| 08/15/2000 | US6103498 Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof |
| 08/15/2000 | US6103497 Human S100 proteins |
| 08/15/2000 | US6103495 Direct expression of peptides into culture media |
| 08/15/2000 | US6103494 Nucleotide sequences which code protein associated with immmune response; for the detection of flea allergy dermatitis; for the detection of modulators of immune response |
| 08/15/2000 | US6103491 Methods and compositions for identifying morphogen analogs |
| 08/15/2000 | US6103487 Detecting modulators that suppress the activity of a transferases; anticarcinogenic agents |
| 08/15/2000 | US6103483 Labeling a polypeptide having a truncated portion of a prosaposin molecule, with a light sensitive probe, contacting probe with a sperm sample and exposing to a light source, measuring anount of probe per sperm which reacts with light |
| 08/15/2000 | US6103477 Rho protein |
| 08/15/2000 | US6103475 Excitatory amino acid receptor protein expression testing methods |
| 08/15/2000 | US6103469 A polynucleotide which encodes a polypeptide; diagnosis and therapy; anticarcinogenic and antiinflammatory agents |
| 08/15/2000 | US6103239 Modified HGP-30 heteroconjugates, compositions and methods of use |
| 08/15/2000 | US6103237 More stable to purification than wild type mature hk2 polypeptide. |
| 08/15/2000 | US6103234 Antibody to an inflammatory cytokine, said inflammatory cytokine comprising a mature macrophage inflammatory protein -2 (mmip-2) |
| 08/15/2000 | US6103233 Cellular and serum protein anchors and conjugates |
| 08/15/2000 | US6103232 Use of antibodies to the central nervous system myelin associated proteins; the monoclonal antibody in-1 and in-2 may be used to promote neurite outgrowth of nerve fibers over long distances in spinal cord lesions. |
| 08/15/2000 | US6103231 Antibiotic stalobacins |
| 08/15/2000 | US6103230 Methods for promoting wound healing and treating transplant-associated vasculopathy |
| 08/15/2000 | US6103228 Antibiotic-producing and metabolite-producing bacillus subtilis strain that exhibits insecticidal activity |
| 08/15/2000 | US6103226 Co-transfecting the cell with one or more expression vectors containing polynucleotides that encode tyrosine hydroxylase, aromatic l-amino acid decarboxylase and gtp cyclohydrolase. |
| 08/15/2000 | US6103224 N∇2 CSF-1 (short form) and carboxy truncated fragments thereof |
| 08/15/2000 | US6103122 Filter sheet for purifying photoresist composition |
| 08/15/2000 | CA2196431C Icam-4 materials and methods |
| 08/15/2000 | CA2142861C Novel uses of il-4 and/or il-10, and antibodies against the same |
| 08/15/2000 | CA2046601C Production and use of anthelmintic agents and protective immunogens |
| 08/15/2000 | CA1341087C Medicaments including hyaluronic acid as a drug delivery system |
| 08/15/2000 | CA1341083C Purified recombinant interleukin-2 and process for recovering and purifying same |
| 08/10/2000 | WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/10/2000 | WO2000046390A1 T helper cell epitopes |
| 08/10/2000 | WO2000046380A2 Fibroblast growth factor receptor-immunoglobulin fusion |
| 08/10/2000 | WO2000046371A1 Tau-conotoxin peptides |
| 08/10/2000 | WO2000046367A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b |
| 08/10/2000 | WO2000046361A1 Inhibition of the mhc class ii antigen presentation pathway and presentation to cd4+ cells |
| 08/10/2000 | WO2000046350A1 Production of biomedical peptides and proteins in plants using transcomplementation systems |
| 08/10/2000 | WO2000046344A2 Non-stochastic generation of genetic vaccines and enzymes |
| 08/10/2000 | WO2000046249A1 Method for producing il-1ra, a therapeutically active protein from body fluids |
| 08/10/2000 | WO2000046248A1 Use of agonists or antagonists of mip-3a in therapy |
| 08/10/2000 | WO2000046246A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 08/10/2000 | WO2000046245A2 Human antibiotic proteins |
| 08/10/2000 | WO2000046244A1 cDNA SEQUENCE OF AN INTERACTOR FANCIP1 OF THE FANCONI ANAEMIA PROTEIN OF COMPLEMENTATION GROUP A |
| 08/10/2000 | WO2000046240A2 Polypeptides involved in immune response |
| 08/10/2000 | WO2000046237A1 Brain-derived alkali-soluble immunoregulatory composition |
| 08/10/2000 | WO2000046236A2 Novel rgs-containing molecules and uses thereof |
| 08/10/2000 | WO2000046147A2 Therapeutic calcium phosphate particles and methods of manufacture and use |
| 08/10/2000 | WO2000045871A1 Highly-mineralized osteogenic sponge compositions, and uses thereof |
| 08/10/2000 | WO2000045870A1 Osteogenic paste compositions and uses thereof |
| 08/10/2000 | WO2000045853A2 Treatment of tumors with genetically engineered herpes virus |
| 08/10/2000 | WO2000045851A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 08/10/2000 | WO2000045848A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use |
| 08/10/2000 | WO2000045838A1 A METHOD FOR TARGETED DEGRADATION OF INTRACELLULAR PROTEINS IN VIVO OR $i(EX VIVO) |
| 08/10/2000 | WO2000045837A1 Novel use within transplantation surgery |
| 08/10/2000 | WO2000045836A1 Uses of thank, a tnf homologue that activates apoptosis |
| 08/10/2000 | WO2000045835A1 Vascular endothelial growth factor-2 |
| 08/10/2000 | WO2000045834A2 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease |